Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Research news

The silencing team

Tudor Toma

Author affiliations

Citation and License

Genome Biology 2002, 3:spotlight-20020408-01  doi:10.1186/gb-spotlight-20020408-01


The electronic version of this article is the complete one and can be found online at:


Published:8 April 2002

© 2002 BioMed Central Ltd

Research news

Inactivation of tumor suppressor genes is an essential stage in the development of human cancer but the extent of involvement of epigenetic silencing and hypermethylation in this process remains unclear. In the April 4 issue of Nature, Ina Rhee and colleagues from Johns Hopkins University School of Medicine, show that two enzymes, DNMT1 and DNMT3b, cooperate to silence genes and maintain DNA methylation in human cancer cells.

Rhee et al. worked on a colorectal cancer cell line and observed that genetic disruption of both DNMT1 and DNMT3b eliminated nearly all methyltransferase activity and reduced genomic DNA methylation by greater than 95%. This resulted in demethylation of repeated sequences, loss of insulin-like growth factor II (IGF2) imprinting, abrogation of silencing of the tumor suppressor gene p16INK4a and growth suppression (Nature 2002, 416:552-556).

These results "establish that methylation is essential for silencing tumor suppressor genes in human cancer cells. It will be of interest to determine whether these results apply to other human cell types," concluded the authors.

References

  1. [http://www.nature.com ] webcite

    Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, et al.: DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002, 416:552-556.

  2. [http://infonet.welch.jhu.edu/som/ ] webcite

    InfoNet, Johns Hopkins University School of Medicine